Local Oncologist Releases New Research on Breast Cancer Treatment

Highlands Oncology Group Physician Published in Medical Journal for Breast Cancer Research

Fayetteville (I-Newswire) December 13, 2013 - Dr. J. Thaddeus Beck, of Highlands Oncology Group (HOG), has been published in Current Medical Research & Opinion. The journal spotlights new research on treatment options for patients suffering from specific breast cancers.

The research entitled "Health-Related Quality of Life and Disease Symptoms in Postmenopausal Women With HR+, HER2- Advanced Breast Cancer Treated With Everolimus Plus Exemestane Versus Exemestane Monotherapy" has recently reached final publication.

The study tested a new melange of treatments and indicates that the newer targeted therapy can produce better results while preserving the patient's quality of life.

Breast cancer is a pervasive disease in the U.S. and extensive research is needed.

About 1 in 8 women will be diagnosed with invasive breast cancer in the U.S, according to Breastcancer.org, a non-profit organization dedicated to providing information and community to people affected by the disease. About 2.8 million women in the U.S. have a history of breast cancer, according to the website.

Trials collaborating the research were administered by physicians internationally. Dr. Beck co-wrote the research and acted as an administrator of the trial.

"This analysis confirms that better treatment results can be achieved with improved quality of life," Dr. Beck said. "Highlands Cancer Center is grateful to the patients that participated in this groundbreaking study."

Current Medical Research & Opinion is a peer-reviewed medical journal established in 1972. Its mission is to "validate high quality articles through rigorous peer review, and to be a leader in transparency by facilitating a collaborative and honest approach to publication," according to its website.

As the leading cancer treatment and research facility in Northwest Arkansas, HOG is dedicated to the advancement of cancer treatment to provide patients with the best possible care and results.

Read the study here: http://www.rti.org/publications/abstract.cfm?pubid=21520


Highlands Oncology Group is a state-of-the-art facility, with a world-class team of specialists, that is committed to providing premier cancer treatment and to enhancing the quality of life of patients and their loved ones. Highlands Oncology group provides this in a friendly, comfortable environment conveniently located in Northwest Arkansas. Highlands offers the latest technology of diagnostic imaging and radiation therapies, on-site labs, a pharmacy and an infusion center. They also offer access to clinical trials, multidisciplinary clinics and support groups. Highlands Oncology Group is helping patients win the battle against cancer every day.

For more information visit www.HighlandsOncologyGroup.com.

About The Artist Evolution

The Artist Evolution is a boutique marketing, design and campaign management firm. We are available    More..as a constant marketing resource. We have the tools and experience to make your marketing campaign a success.Less..

Contact Information

The Artist Evolution
Derek Champagne
1753 N College
Ste 203
Phone : 4792220399

Published in:

Medical > Cancer

Published On:

December 13, 2013

Print Release:

Print Release

Visit The Artist Evolution Website

If you have questions regarding information in this press release contact the company listed above. I-Newswire.com is a press release service and not the author of this press release.The information that is on or available through this site is for informational purposes only and speaks only as of the particular date or dates of that information. As some companies and PR Agencies submit their press releases once per week,month or quarter, make sure to check the official company website for accurate release dates as our site displays the I-Newswire.com press release distribution date only.We do not guarantee the accuracy or completeness of information on or available through this site, and we are not responsible for or omissions in that information or for actions taken in reliance on that information.